Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US7078494B1 · kind B1 · utility
32Cited by
3References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2000 |
| Grant date | Jul 18, 2006 |
| Priority date | — |
| Expiry date | Jun 14, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/244
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Polynucleotides encoding the IL-13 receptor and fragments thereof are disclosed. IL-13 receptor proteins, methods for their production, inhibitors of binding of IL-13 and its receptor and methods for their identification are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.